Chien Wade, Varvares Mark A, Hadlock Tessa, Cheney Mack, Deschler Daniel G
Department of Otology and Laryngology, Harvard Medical School , Boston, Massachusetts 02114, USA.
Laryngoscope. 2005 Jun;115(6):973-6. doi: 10.1097/01.MLG.0000163539.97485.F4.
The success of microvascular free-tissue transfer to the head and neck has been greatly increased secondary to increased experience, yet postoperative anticoagulation continues to be routinely used to prevent pedicle thrombosis. However, there is currently no consensus as to what the ideal regimen, if any, is recommended for postoperative anticoagulation. This study reviews the outcome and incidence of perioperative complications in patients undergoing free flaps for head and neck reconstruction, using a simple postoperative anticoagulation regimen of aspirin and subcutaneous heparin (SQH).
Retrospective chart review.
With institutional review board approval, the charts of 261 patients undergoing free flap reconstruction from January 2000 to January 2004 were retrospectively reviewed. Patients who received a standard postoperative anticoagulation regimen of SQH (5000 U SC bid) and aspirin (325 mg PO qd) were included in the study (216 patients). Charts were reviewed for postoperative complications, specifically for free flap failure, vascular compromise (arterial insufficiency/venous congestion), and hematoma.
There were six flap failures (2.8%), resulting in an overall free flap survival rate of 97.2%. There were six patients with venous congestion of the flap that required neck exploration (2.8%), and 12 patients with postoperative hematoma (5.6%), requiring surgical intervention.
The free flap survival rate in patients undergoing head and neck reconstruction using this simple anticoagulation regimen of aspirin and SQH appears to be equivalent to the free flap survival rate in patients using other anticoagulation agents. In addition, aspirin and SQH do not increase the incidence of postoperative hematoma when compared with the other anticoagulation agents. Therefore, aspirin and SQH appear to be reliable postoperative anticoagulation agents for patients undergoing head and neck reconstruction using free flaps.
由于经验的增加,头颈部微血管游离组织移植的成功率已大幅提高,但术后抗凝仍被常规用于预防蒂部血栓形成。然而,目前对于术后抗凝推荐何种理想方案(若有的话)尚无共识。本研究采用阿司匹林和皮下肝素(SQH)的简单术后抗凝方案,回顾了接受游离皮瓣进行头颈部重建患者围手术期并发症的结果和发生率。
回顾性图表审查。
经机构审查委员会批准,对2000年1月至2004年1月期间接受游离皮瓣重建的261例患者的图表进行回顾性审查。接受SQH(5000 U皮下注射,每日两次)和阿司匹林(325 mg口服,每日一次)标准术后抗凝方案的患者纳入研究(216例患者)。审查图表以了解术后并发症,特别是游离皮瓣失败、血管受损(动脉供血不足/静脉淤血)和血肿情况。
有6例皮瓣失败(2.8%),总体游离皮瓣存活率为97.2%。有6例皮瓣静脉淤血患者需要进行颈部探查(2.8%),12例患者出现术后血肿(5.6%),需要手术干预。
使用阿司匹林和SQH这种简单抗凝方案进行头颈部重建的患者,其游离皮瓣存活率似乎与使用其他抗凝剂的患者的游离皮瓣存活率相当。此外,与其他抗凝剂相比,阿司匹林和SQH不会增加术后血肿的发生率。因此,对于接受游离皮瓣进行头颈部重建的患者,阿司匹林和SQH似乎是可靠的术后抗凝剂。